Incidence, Treatment and Outcome After Acute Mesenteric Ischemia in the Region of Västra Götaland, 2000-2023.

NCT07274306 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2446

Last updated 2025-12-10

No results posted yet for this study

Summary

The goal of this retrospective observational study is to describe the incidence and outcome of patients diagnosed with acute mesenteric ischemia (AMI) in the Västra Götaland region of Sweden between 2000-2023. The main questions it aims to answer are:

* What was the observed incidence and outcome, and how did it change during the time period?
* How did socioeconomic factors influence incidence and outcome of AMI?
* What main surgical approaches were selected for these patients?
* What was the distribution of anticoagulant use in the cohort, and what effect did the introduction of new oral anticoagulants (NOAC) have on incidence and mortality in AMI?
* What was the prevalence of Short Bowel Syndrome (SBS) after surgical intervention?

Participants were obtained from the regional diagnosis registry. Additional datapoints were obtained from the Swedish statistics bureau and pharmaceutical registers.

Conditions

  • Mesenteric Artery Ischemia

Sponsors & Collaborators

  • Gothia Forum - Center for Clinical Trial

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-24
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07274306 on ClinicalTrials.gov